Literature DB >> 9578519

Felbamate: 1997 update.

J M Pellock, M J Brodie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9578519     DOI: 10.1111/j.1528-1157.1997.tb00061.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  13 in total

1.  Seizure treatment in transplant patients.

Authors:  Paul W Shepard; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

2.  Complex Partial Seizures in Children.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-09       Impact factor: 3.598

Review 3.  Combination therapy in epilepsy: when and what to use.

Authors:  Patrick Kwan; Martin J Brodie
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Currently available antiepileptic drugs.

Authors:  Steven C Schachter
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 5.  The star systems: overview and use in determining antiepileptic drug choice.

Authors:  M J Brodie; P Kwan
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

Review 6.  Pharmacotherapy for Focal Seizures in Children and Adolescents.

Authors:  Clare E Stevens; Carl E Stafstrom
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

7.  Seizure management in the setting of hepatic disease.

Authors:  Jane G Boggs
Journal:  Curr Treat Options Neurol       Date:  2011-08       Impact factor: 3.598

Review 8.  The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Authors:  Dean P Sarco; Blaise F D Bourgeois
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 9.  Felbamate in epilepsy therapy: evaluating the risks.

Authors:  J M Pellock
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

Review 10.  What constitutes a relevant animal model of the ketogenic diet?

Authors:  Gregory L Holmes
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.